Related Experiment Video

Updated: Oct 20, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K

Advanced Heart Failure in Special Population: Cardiomyopathies and Myocarditis

Davide Stolfo1, Valentino Collini1, Gianfranco Sinagra1

  • 1Cardiovascular Department, Azienda Sanitaria Universitaria Integrata, Trieste, Italy.

Heart Failure Clinics
|September 13, 2021
PubMed

Insights

Cardiomyopathies, a diverse group of heart muscle diseases, are a significant cause of heart failure in young people. Understanding their varied causes and presentations is crucial for effective treatment and managing advanced heart failure.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Genetics

Background:

  • Cardiomyopathies represent a diverse spectrum of heart muscle diseases.
  • They are a leading cause of heart failure (HF), particularly in younger populations.
  • Varied etiologies, pathophysiological mechanisms, and phenotypes complicate diagnosis and treatment.

Purpose of the Study:

  • To review the heterogeneity of cardiomyopathies.
  • To discuss their impact on heart failure development and prognosis.
  • To highlight the challenges in managing different cardiomyopathy subtypes.

Main Methods:

  • Literature review of cardiomyopathy classifications and mechanisms.
  • Analysis of epidemiological data on heart failure causes.
  • Synthesis of clinical presentations and treatment strategies.

Main Results:

  • Dilated cardiomyopathy is the most common cause of HF.
  • Advanced HF in hypertrophic, restrictive, and arrhythmogenic cardiomyopathies indicates a poor prognosis.
  • Fulminant myocarditis can lead to acute HF or irreversible end-stage left ventricular failure.

Conclusions:

  • Cardiomyopathies require tailored management due to their heterogeneity.
  • Early recognition and intervention are vital for improving outcomes in HF patients.
  • Further research into specific pathophysiological pathways may yield novel therapeutic targets.

Keywords:
Advanced heart failureArrhythmogenic ventricular dysplasiaCardiomyopathiesGenetic syndromesHypertrophic cardiomyopathyLeft ventricular non-compaction cardiomyopathyMyocarditisRestrictive cardiomyopathy

More Related Videos

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.7K
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

8.7K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
79
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
67
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
157
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
74
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
57